Aigen Investment Management, LP Theravance Biopharma, Inc. Transaction History

Aigen Investment Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$9.87 - $11.44 $234,106 - $271,345	23,719 New	23,719 $257,000
Q4 2020 Feb 12, 2021	SELL	$14.89 - $20.16 $69,432 - $94,006	-4,663 Closed	0 $0
Q3 2020 Nov 06, 2020	SELL	$14.79 - $22.49 $129,649 - $197,147	-8,766 Reduced 65.28%	4,663 $69,000
Q2 2020 Aug 10, 2020	BUY	$20.64 - $30.69 $71,765 - $106,709	3,477 Added 34.94%	13,429 $282,000
Q1 2020 May 08, 2020	BUY	$17.84 - $31.21 $177,204 - $310,008	9,933 Added 52278.95%	9,952 $230,000
Q4 2019 Feb 04, 2020	BUY	$16.12 - $25.89 $306 - $491	19 New	19 $0

122

47.3M

200

12.8K

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $666M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.